文献速递呼吸危重症与机械通气

ARDS研究五十年:急性呼吸窘迫综合征长期随访对危重症后医疗复杂性的启示

Fifty Years of Research in ARDS. Long-Term Follow-up after Acute Respiratory Distress Syndrome. Insights for Managing Medical Complexity after Critical Illness.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

该综述回顾ARDS研究五十年,指出危重症并非单一疾病状态,而是多种异质性疾病及健康轨迹的终末表现,ARDS是急性及长期预后的重要风险修饰因素但不能孤立定义患者结局。未来需关注病前健康状态、组织损伤易感性和韧性差异,重视ICU实践对发病率的贡献,并与患者及照护者透明沟通、确保治疗与目标一致,通过跨专业协作优化康复和重返社会。

要点

  • 危重症是医疗复杂性和多病共存的新发或加重标志,而非独立疾病实体。
  • ARDS是急性及长期预后的重要风险修饰因素,但不能孤立定义患者结局。
  • 未来需关注病前健康状态、组织损伤易感性和患者韧性差异。

核心结论

  • 危重症并非离散的疾病状态或综合征,而是多种异质性疾病状态及其不同健康轨迹导致需要高级生命支持的极端疾病状态,是新发或加重医疗复杂性和多病共存的标志。
  • ARDS仍是急性及长期预后的重要、增量性损伤和风险修饰因素,但不能孤立地定义患者或其结局。
  • 未来研究和临床议程需聚焦患者病前健康状态、组织损伤内在易感性和多样韧性,并对ICU实践所致发病率承担责任。

主要发现

  • 五十年前,重症医学同行识别出严重肺损伤综合征,将一组入院诊断各异的患者统一起来。
  • 危重症是多种异质性疾病状态及其不同健康轨迹的终末表现,需要特定地理位置的先进生命支持。
  • ARDS是急性及长期预后的重要风险修饰因素,但并非患者结局的唯一决定因素。

临床怎么用

  • 与患者及照护者就危重症的真实发病后果进行坦诚透明的沟通。
  • 对创新性、实验性或高风险医疗和手术操作明确告知发病率并获取知情同意。
  • 确保持续治疗水平与患者及照护者的目标和价值观一致。
  • 通过跨专业和多学科协作改造现有复杂照护路径,促进最佳康复和重返工作与社区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Critical illness is not a discrete disease state or syndrome. It is the culmination of a multiplicity of heterogeneous disease states and their varied health trajectories leading to extreme illness that requires advanced life support in a distinct geographic location in the hospital. It is a marker of newly acquired or worsened medical complexity and multimorbidities. Fifty years ago, distinguished critical care colleagues identified a syndrome of severe lung injury that united a group of patients with disparate admitting diagnoses. Acute respiratory distress syndrome continues to represent an important, incremental insult and risk modifier of acute and longer-term outcome, but it does not solely define our patients or their outcomes in isolation. Over the next 50 years, our research and clinical agenda needs to sharpen our lens on the fundamental importance of our patients' pre-critical illness health status, their intrinsic susceptibilities to tissue injury, and their innate and varied resiliencies. We need to take responsibility for the contribution that we make to morbidity through our practice in the intensive care unit each day. Engagement in frank and transparent communication with our patients and their caregivers about the very real and morbid consequences of being this sick is essential. We must enforce explicit consent about the morbidity of innovative, experimental, or high-risk medical and surgical procedures and ensure that our ongoing level of treatment aligns with patients' and caregivers' goals and values. Interprofessional and multidisciplinary collaboration is crucial to modify existing complex care pathways for our patients and their families to foster optimal rehabilitation and reintegration into the workplace and community.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Herridge MS. Fifty Years of Research in ARDS. Long-Term Follow-up after Acute Respiratory Distress Syndrome. Insights for Managing Medical Complexity after Critical Illness. Am J Respir Crit Care Med. 2017. PMID: 28767270. doi:10.1164/rccm.201704-0815ED

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。